Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 09-2019 | 03-2019 | 09-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 235 | 67 | 628 | 1,621 | 2,814 |
| Receivables | 325 | 518 | 111 | 21 | 0 |
| TOTAL | $567 | $616 | $759 | $1,641 | $2,814 |
| Non-Current Assets | |||||
| PPE Net | 31 | 1 | 1 | N/A | N/A |
| TOTAL | $31 | $1 | $1 | $0 | $0 |
| Total Assets | $597 | $617 | $760 | $1,641 | $2,814 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 594 | 779 | 382 | 117 | 0 |
| Accrued Expenses | 40 | 31 | 19 | 101 | 88 |
| TOTAL | $711 | $813 | $427 | $218 | $128 |
| Non-Current Liabilities | |||||
| TOTAL | $27 | $0 | $0 | $0 | $0 |
| Total Liabilities | $737 | $813 | $427 | $218 | $128 |
| Shareholders' Equity | |||||
| Common Shares | 83,520 | 84,573 | 89,218 | 86,471 | 93,015 |
| Retained earnings | -85,878 | -84,933 | -88,967 | -85,528 | -90,329 |
| Other shareholders' equity | 2,217 | 164 | 82 | 480 | 0 |
| TOTAL | $-140 | $-196 | $333 | $1,423 | $2,686 |
| Total Liabilities And Equity | $597 | $617 | $760 | $1,641 | $2,814 |